麻豆传媒

SUMMIT trial able to show clinical benefit beyond quality-of-life improvement

BPROAD trial replicates SPRINT trial findings in diabetes population in China

Asynchronous automated order approach boosts statin prescribing

Intervention trial shows impact that could pay off long-term

Monoclonal antibody promises substantial lipid lowering with just one injection every 3 months

Huge trial from China reinforces the message from SPRINT for higher-risk hypertensive patients

But whether the small absolute gain shown in ARTESiA is worth the bleeds is another question

Preliminary data support concept of "molecular surgery" on PCSK9 gene

Benefit finally proven in clinical trial

Clinical trial affirms a better initial strategy

Dietary change produces clinically relevant BP changes within a week

Warfarin does a good enough job alone without adding aspirin

Reduced angina frequency with anti-anginal meds out of the picture

For patients with anemia, trial suggests the commonly used restrictive strategy might not be best